市場調査レポート

商品コード

細胞凍結保存の世界市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Cell Cryopreservation Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年11月26日
発行: Market Xcel - Markets and Data
ページ情報: 英文 243 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 646,065円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 818,349円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,177,274円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の細胞凍結保存の市場規模は、2023年の95億3,000万米ドルから2031年に454億9,000万米ドルに達すると予測され、予測期間の2024年～2031年にCAGRで21.58%の成長が見込まれます。市場の成長を支えているのは、さまざまな疾患における細胞療法の利用の拡大、バイオバンクに対する要求の増加、体外受精クリニックからの要求の高まり、生物学的検体を長期保存する活動の拡大、先進技術を利用した機器を導入する主要市場企業の取り組みの高まりなどです。

さらに、幹細胞や臓器、血液の提供を推進する各国政府の取り組みが、さまざまな民族間で活発化していることも、細胞凍結保存市場の成長を後押ししています。2023年に、ウェールズとイングランドの50の団体やコミュニティグループが、アジアや黒人のコミュニティの健康格差に取り組む政府の取り組みの一環として、約89万米ドルの資金提供を受けました。以前はCommunity Investment Schemeとして知られていたCommunity Grants Programは、National Health Service Blood and Transplant（NHSBT）によって管理され、より多くのアジアや黒人の人々がドナーになることを奨励するプロジェクトを実施する地域団体に資金を援助するものです。

さらに、主要企業による新しい先進の製品や技術の可用性の強化への取り組みの高まりも、世界の細胞凍結保存市場の拡大にプラスの影響を与えています。2024年9月、Dover Corporation傘下のColder Products Company（CPC）は、遺伝子・細胞治療処理に使用される凍結カセットに直接適合する機能を持つ、新しい無菌マイクロコネクターの発売を発表しました。凍結保存は、治療が患者に提供される前に発生する保管中や製品出荷中の材料の機能低下を最小化するのに役立ちます。同社のMicroCNX ULTコネクターは、チューブの滅菌接続に効率的でシンプルな方法を提供し、刺激の強い化学品にも対応しています。このような発売により、バイオセーフティキャビネットの外での無菌接続が可能になり、生物学的検体の輸送が容易になると予測されます。

当レポートでは、世界の細胞凍結保存市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

市場規模の分析と予測
- 金額
市場シェアの分析と予測
- 製品別
- 用途別
- エンドユーザー別
- 地域別
- 市場シェア分析：企業別（金額）（上位5社とその他 - 2023年）
市場マップ分析（2023年）
- 製品別
- 用途別
- エンドユーザー別
- 地域別

第5章北米の細胞凍結保存市場の見通し（2017年～2031年）

市場規模の分析と予測
- 金額
市場シェアの分析と予測
- 製品別
- 用途別
- エンドユーザー別
- シェア：国別
各国の市場の評価
- 米国の細胞凍結保存市場の見通し（2017年～2031年）
- カナダ
- メキシコ

第6章欧州の細胞凍結保存市場の見通し（2017年～2031年）

ドイツ
フランス
イタリア
英国
ロシア
オランダ
スペイン
ポーランド

第7章アジア太平洋の細胞凍結保存市場の見通し（2017年～2031年）

インド
中国
日本
オーストラリア
ベトナム
韓国
インドネシア
フィリピン

第8章南米の細胞凍結保存市場の見通し（2017年～2031年）

ブラジル
アルゼンチン

第9章中東・アフリカの細胞凍結保存市場の見通し（2017年～2031年）

サウジアラビア
アラブ首長国連邦
南アフリカ
イスラエル

第10章需給分析

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

第13章 PESTLE分析

第14章価格分析

第15章市場力学

市場促進要因
市場の課題

第16章市場の動向と発展

第17章規制枠組みとイノベーション

臨床試験
規制当局の承認

第18章特許情勢

第19章ケーススタディ

第20章競合情勢

マーケットリーダー上位5社の競合マトリクス
上位5社のSWOT分析
主要企業上位10社の情勢
- Merck & Co., Inc.
- Thermo Fisher Scientific Inc.
- Lonza Group Ltd.
- GE HealthCare Technologies Inc.
- BioLife Solutions Inc.
- Sartorius AG
- STEMCELL Technologies Canada Inc.
- Artivion, Inc.
- Takara Bio Inc.
- Corning Incorporated

第21章戦略的推奨

第22章当社について、免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 3. Global Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 4. Global Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 5. Global Cell Cryopreservation Market Share (%), By Region, 2017-2031F
Figure 6. North America Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 7. North America Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 8. North America Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 9. North America Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 10. North America Cell Cryopreservation Market Share (%), By Country, 2017-2031F
Figure 11. United States Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 12. United States Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 13. United States Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 14. United States Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 15. Canada Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 16. Canada Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 17. Canada Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 18. Canada Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 19. Mexico Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 20. Mexico Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 21. Mexico Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 22. Mexico Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 23. Europe Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 24. Europe Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 25. Europe Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 26. Europe Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 27. Europe Cell Cryopreservation Market Share (%), By Country, 2017-2031F
Figure 28. Germany Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 29. Germany Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 30. Germany Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 31. Germany Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 32. France Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 33. France Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 34. France Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 35. France Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 36. Italy Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 37. Italy Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 38. Italy Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 39. Italy Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 40. United Kingdom Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 41. United Kingdom Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 42. United Kingdom Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 43. United Kingdom Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 44. Russia Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 45. Russia Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 46. Russia Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 47. Russia Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 48. Netherlands Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 49. Netherlands Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 50. Netherlands Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 51. Netherlands Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 52. Spain Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 53. Spain Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 54. Spain Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 55. Spain Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 56. Turkey Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 57. Turkey Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 58. Turkey Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 59. Turkey Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 60. Poland Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 61. Poland Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 62. Poland Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 63. Poland Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 64. South America Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 65. South America Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 66. South America Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 67. South America Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 68. South America Cell Cryopreservation Market Share (%), By Country, 2017-2031F
Figure 69. Brazil Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 70. Brazil Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 71. Brazil Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 72. Brazil Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 73. Argentina Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 74. Argentina Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 75. Argentina Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 76. Argentina Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 77. Asia-Pacific Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 78. Asia-Pacific Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 79. Asia-Pacific Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 80. Asia-Pacific Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 81. Asia-Pacific Cell Cryopreservation Market Share (%), By Country, 2017-2031F
Figure 82. India Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 83. India Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 84. India Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 85. India Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 86. China Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 87. China Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 88. China Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 89. China Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 90. Japan Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 91. Japan Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 92. Japan Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 93. Japan Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 94. Australia Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 95. Australia Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 96. Australia Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 97. Australia Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 98. Vietnam Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 99. Vietnam Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 100. Vietnam Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 101. Vietnam Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 102. South Korea Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 103. South Korea Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 104. South Korea Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 105. South Korea Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 106. Indonesia Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 107. Indonesia Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 108. Indonesia Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 109. Indonesia Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 110. Philippines Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 111. Philippines Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 112. Philippines Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 113. Philippines Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 114. Middle East & Africa Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 115. Middle East & Africa Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 116. Middle East & Africa Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 117. Middle East & Africa Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 118. Middle East & Africa Cell Cryopreservation Market Share (%), By Country, 2017-2031F
Figure 119. Saudi Arabia Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 120. Saudi Arabia Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 121. Saudi Arabia Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 122. Saudi Arabia Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 123. UAE Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 124. UAE Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 125. UAE Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 126. UAE Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 127. South Africa Cell Cryopreservation Market, By Value, In USD Billion, 2017-2031F
Figure 128. South Africa Cell Cryopreservation Market Share (%), By Product, 2017-2031F
Figure 129. South Africa Cell Cryopreservation Market Share (%), By Application, 2017-2031F
Figure 130. South Africa Cell Cryopreservation Market Share (%), By End-user, 2017-2031F
Figure 131. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 132. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX12252

Global cell cryopreservation market is projected to witness a CAGR of 21.58% during the forecast period 2024-2031, growing from USD 9.53 billion in 2023 to USD 45.49 billion in 2031. The market's growth is supported by the increasing utilization of cell therapies in various diseases, rising requirements for biobanks, increasing requirements from IVF clinics, growing efforts to preserve biological specimens for longer periods, and rising efforts of the key players of the market to introduce technologically advanced equipment.

Additionally, the rising efforts of different governments to promote stem cells, organs, and blood donations among different ethnicities are also boosting the growth of the cell cryopreservation market. In 2023, fifty organizations and community groups across Wales and England received a share from funding of approximately USD 890,000 (£685,000) as part of the government's efforts to tackle health inequalities among Asian and Black communities. Previously known as the Community Investment Scheme, the Community Grants Program is managed by the National Health Service Blood and Transplant (NHSBT) and aids in funding community organizations to deliver projects that encourage more Asian and Black individuals to become donors.

Furthermore, the rising efforts of leading companies to augment the availability of novel and advanced products and technologies are also positively influencing the expansion of the global cell cryopreservation market. In September 2024, Colder Products Company (CPC), a part of the Dover Corporation, announced the launch of a novel aseptic micro-connector that has the ability to fit directly into the freeze cassettes used in gene and cell therapy processing. Cryopreservation aids in minimizing material loss of function during storage and product shipment, which occurs prior to therapies being delivered to patients. The company's MicroCNX ULT connectors provide an efficient and simple method for the sterile connection of tubing and are also compatible with harsh chemicals. Such launches are expected to aid in creating sterile connections outside the biosafety cabinets, allowing for easy transport of biological specimens.

Increasing Construction of Biobanks Boosts Market Demand

The rapid expansion of disease prevention research and increasing requirement for targeted therapies and precision medicine are propelling the requirement for biobanks. Various governments also provide funding and donations to biobanks to support and promote research activities across various domains. In February 2024, the UK government provided an additional USD 27 million (£21 million) for the USD 97 million (£75 million) UK Biobank Limited in Manchester.

Additionally, various integrated healthcare providers are also investing in the construction of biobank facilities in different regions across the globe. In May 2024, CIC Innovation Services LLC and CHA Medical & Bio Group signed a memorandum of understanding for establishing an open innovation center focusing on innovation and research around the Cell Gene Biobank (CGB). Both companies agreed to collaborate to create a biotech-focused innovation ecosystem for supporting and attracting biotech companies and related ventures to CGB, which is being constructed by the CHA Medical & Bio Group in Pangyo, South Korea. Such activities are expected to boost the growth of the research sector and positively influence the expansion of the global cell cryopreservation market.

Technological Advancements Support Market Expansion

The growing efforts by various biotech companies to bolster the development and availability of novel cell cryopreservation technologies to increase convenience and redefine standards for cryopreservation are boosting the global cell cryopreservation market growth. In October 2024, Nucleus Biologics, LLC, one of the leading providers of bioprocessing and cell culture solutions for the gene and cell therapy sector, launched NB-KUL DF, a chemically defined, DMSO-free cryomedia set to redefine the standards of cryopreservation. NB-KUL DF outperforms other DMSO-free options in cell expansion, viability, and recovery. Additionally, NB-KUL DF eliminates the issues associated with DMSO-based media, such as the requirement for complex wash steps, patient issues, and additional variability and costs. Such launches mark a new era for cell cryopreservation for therapies and showcase the biotech companies' efforts to create products that make therapies more accessible and consistent for patients.

Additionally, various biotech companies are entering into collaborations and partnerships with others to accelerate the development of novel products and technologies. In October 2023, Cryoport, Inc. and NMDP BioTherapies (formerly known as Be The Match BioTherapies) announced a partnership to expand the former's capabilities and provide global cryopreservation and bioprocessing support across Europe and the United States.

IVF Clinics Hold Significant Market Share

The rising cases of infertility and the increasing requirement for the freezing and donating of biological material are propelling the segment's expansion and bolstering the global cell cryopreservation market size. As per the estimates of the World Health Organization (WHO), 1 in 6 adults across the globe experience infertility in their lifetime. Thus, propelling the requirement for effective and dependable cryopreservation solutions to ensure the viability of frozen eggs and sperm for long periods of time. Additionally, the rising cases of infertility are also augmenting the construction of fertility clinics in various regions across the globe, providing lucrative growth opportunities to the market. In June 2024, a new state-of-the-art fertility clinic was opened in Walnut Creek, United States, to address the rising requirement for expert fertility care. The increasing acceptance and awareness of assisted reproductive technologies (ART) is also boosting the demand for cell cryopreservation tools by IVF clinics. Various government and non-government organizations (NGOs) are also working on raising awareness about infertility, destigmatizing ARTs, and promoting education and understanding.

North America Holds Major Market Share

The expansion of the North American cell cryopreservation market is driven by the increasing emphasis on research and development activities, rising investments in the biotech sector, and the presence of advanced healthcare infrastructure. Additionally, the strong presence of leading market players in the region also provides lucrative growth opportunities for the market by ensuring the availability of advanced and novel technologies. The increased product demand can also be attributed to the rising construction of biobanks in countries such as the United States to support medical research for developing new and personalized therapies.

Furthermore, the rising efforts of various companies and research organizations to expedite cell and gene therapy development and manufacturing are also propelling the market's demand. In June 2023, GenScript Biotech Corporation and Comprehensive Cell Solutions, a business unit of New York Blood Center, Inc., announced their partnership to spearhead the development of gene and cell therapies to offer seamless and unique solutions that span apheresis and cell collections through cryopreservation of final therapeutics. The partnership will also focus on aiding drug developers in advancing treatment options for immune disorders and blood cancer. Additionally, the increasing breakthroughs in the region in gene and cell therapies are further augmenting the demand for reliable cryopreservation equipment to support clinical trials, distribution, and manufacturing activities.

Future Market Scenario (2024-2031F)

As per the global cell cryopreservation market analysis, the increasing investments in biobanking, advancements in cryoprotectant formulations, and automated cryopreservation systems are expected to provide lucrative growth opportunities to the market. Private organizations and governments across the globe are significantly investing in establishing biobanks to support drug discovery and disease research. Such initiatives are anticipated to boost the market's growth as biobanking facilities rely on effective cryopreservation technologies for storing biological specimens and ensuring they remain viable for future use. The growing popularity of personalized medicines is also expected to bolster the demand for efficient cell storage solutions, propelling the global cell cryopreservation market demand.

Moreover, the growing focus on cell-based therapies for treating autoimmune diseases, neurological disorders, and cancer, among others, is also expected to bolster the requirement for cell cryopreservation products. According to the estimates of the World Health Organization (WHO), over 35 million new cases of cancer are expected to occur in 2050. Additionally, the market is also expected to benefit from the increasing initiatives that aim to improve the regulatory framework, allowing companies to bring novel products to the market with ease.

Key Players Landscape and Outlook

The rising efforts by the key market players towards novel product launches are providing lucrative growth opportunities for the market. In June 2023, BioLife Solutions Inc, one of the leading suppliers and developers of class-defining bioproduction services and products for gene and cell therapy, announced the launch of their new, large-capacity controlled-rate freezer (CRF). The IntelliRate i67C tabletop freezer fulfills the growing customer requirement for high production of cell therapies. The new CRF has been designed to increase single-batch, LN2 CRF capacity from commercial manufacturing volumes to late- and mid-stage clinical research. Additionally, in October 2024, Cryoport, Inc. announced the launch of their IntegriCell cryopreservation solution provided by Cryoport Systems, along with the opening of their new facility in Texas, United States. The new facility is developed for standardized cryopreservation of leukapheresis material to support the commercialization and development of cell-based therapies. IntegriCell is designed to enhance cell therapy manufacturing efficiency and ensure quality, safety, and product stability to support the development of lifesaving treatment. Such developments and investments are expected to aid the key players in expanding their market share while positively influencing the expansion of the cell cryopreservation market.

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Cell Cryopreservation Market Outlook, 2017-2031F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
4.2. Market Share Analysis & Forecast
- 4.2.1. By Product
  - 4.2.1.1. Cell Freezing Media
    - 4.2.1.1.1. Ethylene Glycol
    - 4.2.1.1.2. Dimethyl Sulfoxide
    - 4.2.1.1.3. Glycerol
    - 4.2.1.1.4. Others
  - 4.2.1.2. Equipment
    - 4.2.1.2.1. Freezers
    - 4.2.1.2.2. Incubators
    - 4.2.1.2.3. Liquid Nitrogen Supply Tanks
  - 4.2.1.3. Consumables
    - 4.2.1.3.1. Cryogenic Vials
    - 4.2.1.3.2. Cryogenic Tubes
    - 4.2.1.3.3. Cooler Boxes/Containers
    - 4.2.1.3.4. Others
- 4.2.2. By Application
  - 4.2.2.1. Stem Cells
  - 4.2.2.2. Oocytes and Embryonic cells
  - 4.2.2.3. Sperm Cells
  - 4.2.2.4. Hepatocytes
  - 4.2.2.5. Others
- 4.2.3. By End-user
  - 4.2.3.1. Biopharmaceutical and Pharmaceutical Companies
  - 4.2.3.2. Research Institutes
  - 4.2.3.3. Biobanks
  - 4.2.3.4. IVF Clinics
  - 4.2.3.5. Others
- 4.2.4. By Region
  - 4.2.4.1. North America
  - 4.2.4.2. Europe
  - 4.2.4.3. Asia-Pacific
  - 4.2.4.4. South America
  - 4.2.4.5. Middle East and Africa
- 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
4.3. Market Map Analysis, 2023
- 4.3.1. By Product
- 4.3.2. By Application
- 4.3.3. By End-user
- 4.3.4. By Region

5. North America Cell Cryopreservation Market Outlook, 2017-2031F*

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
5.2. Market Share Analysis & Forecast
- 5.2.1. By Product
  - 5.2.1.1. Cell Freezing Media
    - 5.2.1.1.1. Ethylene Glycol
    - 5.2.1.1.2. Dimethyl Sulfoxide
    - 5.2.1.1.3. Glycerol
    - 5.2.1.1.4. Others
  - 5.2.1.2. Equipment
    - 5.2.1.2.1. Freezers
    - 5.2.1.2.2. Incubators
    - 5.2.1.2.3. Liquid Nitrogen Supply Tanks
  - 5.2.1.3. Consumables
    - 5.2.1.3.1. Cryogenic Vials
    - 5.2.1.3.2. Cryogenic Tubes
    - 5.2.1.3.3. Cooler Boxes/Containers
    - 5.2.1.3.4. Others
- 5.2.2. By Application
  - 5.2.2.1. Stem Cells
  - 5.2.2.2. Oocytes and Embryonic cells
  - 5.2.2.3. Sperm Cells
  - 5.2.2.4. Hepatocytes
  - 5.2.2.5. Others
- 5.2.3. By End-user
  - 5.2.3.1. Biopharmaceutical and Pharmaceutical Companies
  - 5.2.3.2. Research Institutes
  - 5.2.3.3. Biobanks
  - 5.2.3.4. IVF Clinics
  - 5.2.3.5. Others
- 5.2.4. By Country Share
  - 5.2.4.1. United States
  - 5.2.4.2. Canada
  - 5.2.4.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Cell Cryopreservation Market Outlook, 2017-2031F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Product
      - 5.3.1.2.1.1. Cell Freezing Media
      - 5.3.1.2.1.1.1. Ethylene Glycol
      - 5.3.1.2.1.1.2. Dimethyl Sulfoxide
      - 5.3.1.2.1.1.3. Glycerol
      - 5.3.1.2.1.1.4. Others
      - 5.3.1.2.1.2. Equipment
      - 5.3.1.2.1.2.1. Freezers
      - 5.3.1.2.1.2.2. Incubators
      - 5.3.1.2.1.2.3. Liquid Nitrogen Supply Tanks
      - 5.3.1.2.1.3. Consumables
      - 5.3.1.2.1.3.1. Cryogenic Vials
      - 5.3.1.2.1.3.2. Cryogenic Tubes
      - 5.3.1.2.1.3.3. Cooler Boxes/Containers
      - 5.3.1.2.1.3.4. Others
    - 5.3.1.2.2. By Application
      - 5.3.1.2.2.1. Stem Cells
      - 5.3.1.2.2.2. Oocytes and Embryonic cells
      - 5.3.1.2.2.3. Sperm Cells
      - 5.3.1.2.2.4. Hepatocytes
      - 5.3.1.2.2.5. Others
    - 5.3.1.2.3. By End-user
      - 5.3.1.2.3.1. Biopharmaceutical and Pharmaceutical Companies
      - 5.3.1.2.3.2. Research Institutes
      - 5.3.1.2.3.3. Biobanks
      - 5.3.1.2.3.4. IVF Clinics
      - 5.3.1.2.3.5. Others
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Cell Cryopreservation Market Outlook, 2017-2031F

6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Poland

7. Asia-Pacific Cell Cryopreservation Market Outlook, 2017-2031F

7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines

8. South America Cell Cryopreservation Market Outlook, 2017-2031F

8.1. Brazil
8.2. Argentina

9. Middle East and Africa Cell Cryopreservation Market Outlook, 2017-2031F

9.1. Saudi Arabia
9.2. UAE
9.3. South Africa
9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

15.1. Market Drivers
15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

17.1. Clinical Trials
17.2. Regulatory Approvals

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

20.1. Competition Matrix of Top 5 Market Leaders
20.2. SWOT Analysis for Top 5 Players
20.3. Key Players Landscape for Top 10 Market Players
- 20.3.1. Merck & Co., Inc.
  - 20.3.1.1. Company Details
  - 20.3.1.2. Key Management Personnel
  - 20.3.1.3. Products and Services
  - 20.3.1.4. Financials (As Reported)
  - 20.3.1.5. Key Market Focus and Geographical Presence
  - 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
- 20.3.2. Thermo Fisher Scientific Inc.
- 20.3.3. Lonza Group Ltd.
- 20.3.4. GE HealthCare Technologies Inc.
- 20.3.5. BioLife Solutions Inc.
- 20.3.6. Sartorius AG
- 20.3.7. STEMCELL Technologies Canada Inc.
- 20.3.8. Artivion, Inc.
- 20.3.9. Takara Bio Inc.
- 20.3.10. Corning Incorporated

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

細胞凍結保存の世界市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Cell Cryopreservation Market Assessment, By Product, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の細胞凍結保存市場の見通し（2017年～2031年）

第5章 北米の細胞凍結保存市場の見通し（2017年～2031年）

第6章 欧州の細胞凍結保存市場の見通し（2017年～2031年）

第7章 アジア太平洋の細胞凍結保存市場の見通し（2017年～2031年）

第8章 南米の細胞凍結保存市場の見通し（2017年～2031年）

第9章 中東・アフリカの細胞凍結保存市場の見通し（2017年～2031年）

第10章 需給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析